Safety and Pharmacokinetic Study of Oral MK-8527 QM in Participants at Low-Risk for HIV-1 Infection (MK-8527-007)

Conditions:   HIV;   HIV Pre-exposure Prophylaxis Interventions:   Drug: MK-8527;   Drug: Placebo to MK-8527 Sponsor:   Merck Sharp & Dohme LLC Not yet recruiting

Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials